Dermatology Doctors in Baton Rouge, LA Accepting Medicare

35 Dermatology doctors found. Showing 21 - 35

Joshua Mark Pitre, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-246-9916    Fax: 225-246-4011

John Bretton Brantley, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5220 Flanders Drive, Baton Rouge, LA 70808 Phone: 225-766-5151    Fax: 225-766-8216

Dr. Stephen D Antrobus, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4950 Essen Lane, Suite 301, Baton Rouge, LA 70809 Phone: 225-763-9611    Fax: 225-763-9699

Dr. Emily Burgin Richard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044    Fax: 225-246-9116

Dr. Chad Landon Prather, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6411 Perkins Rd Ste 100, Baton Rouge, LA 70808 Phone: 225-303-9500    Fax: 225-303-9501

Robert N. Earhart, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044

Dr. Ira Hughes Thorla Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10154 Jefferson Hwy, Baton Rouge, LA 70809 Phone: 225-927-5663    Fax: 225-928-7341

Mamina Turegano, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6411 Perkins Rd Ste 100, Baton Rouge, LA 70808 Phone: 225-303-9500    Fax: 225-303-9501

Dr. Shahraam Kamalpour, MD, FAAD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 17050 Medical Center Dr, Baton Rouge, LA 70816 Phone: 225-754-5117    Fax: 225-754-5043

Lindsey Hall, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5326 Odonovan Dr, Baton Rouge, LA 70808 Phone: 225-769-7546    Fax: 225-769-0471

Dr. Maurice Mccall Vick Jr., MD Dermatology - Procedural Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5225 Odonovan, Ste 102, Baton Rouge, LA 70808 Phone: 225-767-2686    Fax: 225-767-2687

Lori Nelson Byrd, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5326 O'donovan Drive, Baton Rouge, LA 70808 Phone: 225-769-7546    Fax: 225-769-0471

Mary Margaret Dobson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5326 Odonovan Drive, Baton Rouge, LA 70808 Phone: 225-769-7546    Fax: 225-769-0471

Dr. William Trent Massengale, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5326 O'donovan Drive, Baton Rouge, LA 70808 Phone: 225-769-7546    Fax: 225-769-0471

Nicole Matths Harrell, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5326 O'dovan Drive, Baton Rouge, LA 70808 Phone: 512-615-3280

News Archive

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other lipid-lowering treatments.

Cedars-Sinai Medical Center announces clinical trial of minimally invasive procedure for opening carotid arteries

Patients who suffer from plaque-related narrowing of a carotid artery but are not good candidates for open surgery may be eligible to participate in a clinical trial at Cedars-Sinai Medical Center of a minimally invasive procedure designed to open carotid arteries the way angioplasty and stenting clear arteries of the heart.

REGEN-COV shown to rapidly reduce SARS-CoV-2 viral load in hospitalized COVID-19 patients

Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.

Gene study sheds new light on lung cancer

A multi-institution team, funded by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), today reported results of the largest effort to date to chart the genetic changes involved in the most common form of lung cancer, lung adenocarcinoma. The findings should help pave the way for more individualized approaches for detecting and treating the nation's leading cause of cancer deaths.

Reuters: Wellpoint targets breast cancer patients for rescission

That tens of thousands of Americans lost their health insurance shortly after being diagnosed with life-threatening, expensive medical conditions has been well documented by law enforcement agencies, state regulators and a congressional committee. ... And a congressional committee last year said WellPoint was one of the worst offenders.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)